- Previous Close
52.30 - Open
52.70 - Bid 52.60 x --
- Ask 53.00 x --
- Day's Range
52.50 - 53.00 - 52 Week Range
51.70 - 71.10 - Volume
8,400 - Avg. Volume
49,587 - Market Cap (intraday)
2.031B - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
17.99 - EPS (TTM)
2.94 - Earnings Date --
- Forward Dividend & Yield 1.28 (2.42%)
- Ex-Dividend Date Jun 17, 2024
- 1y Target Est
--
TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan and Asia. It offers products for cardiovascular, central nervous, gastrointestinal, and others. The company was founded in 1999 and is headquartered in Taipei city, Taiwan. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.
www.tshbiopharm.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 8432.TWO
View MorePerformance Overview: 8432.TWO
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8432.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8432.TWO
View MoreValuation Measures
Market Cap
2.03B
Enterprise Value
1.17B
Trailing P/E
17.98
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.82
Price/Book (mrq)
1.46
Enterprise Value/Revenue
1.05
Enterprise Value/EBITDA
5.77
Financial Highlights
Profitability and Income Statement
Profit Margin
10.14%
Return on Assets (ttm)
6.55%
Return on Equity (ttm)
9.29%
Revenue (ttm)
1.12B
Net Income Avi to Common (ttm)
113.09M
Diluted EPS (ttm)
2.94
Balance Sheet and Cash Flow
Total Cash (mrq)
897.36M
Total Debt/Equity (mrq)
1.26%
Levered Free Cash Flow (ttm)
138.94M